首页> 外文期刊>Pharmacology & Pharmacy >Effect of Biejiajian Oral Liquid on the Expression of RAAS in Hepatic Fibrosis Rats
【24h】

Effect of Biejiajian Oral Liquid on the Expression of RAAS in Hepatic Fibrosis Rats

机译:别家煎口服液对肝纤维化大鼠RAAS表达的影响

获取原文
           

摘要

Objective: To study the effect of Biejiajian Oral Liquid (BOL) on the rennin angiotensin aldosterone system (RAAS) in plasma of hepatic fibrosis rats and in hepatic stellate cell (HSC) of normal rats. We explore the mechanism of BOL on inhibiting the activation of HSC and illustrate its mechanism of anti-hepatic fibrosis further. Methods: SD Rats were divided into 5 groups randomly: normal control group, model group, Enalapril group and BOL groups with different concentration (2.0 g/ml or 1.0 g/ml). Every group was administered with CCl4 and olive oil solution to induce hepatic fibrosis except normal one. Each group was treated with the respective drug for 5 weeks and then got the blood. The level of renin, angiotensin II and aldosterone in the plasma of liver fibrosis rats were detected by the radioimmunoassay. By using reverse transcription-polymerase chain reaction (RT-PCR) to measure the gene expression of the rennin, ACE, angiotensinogen, AT1R and ALD. The AT1R gene expression in normal HSC was determined by the immunohistochemical measurement. Results: BOL could effectively reduce the activity of the PRA, AngIIand ALD, which showed a significant effect on the inhibition of the AngII (P < 0.01). Meanwhile, compared with the normal control group, there was a notable inhibitory action on the PRA of HSC which was administrated by serum containing BOL (P < 0.05). And yet, drug applied group showed no difference with the model group for other factors of the RAAS. Conclusion: BOL can inhibit the expression of RAAS in the rat plasma and can inhibit the expression of the mRNA of renin in the normal HSC, which could be the mechanism of anti-hepatic fibrosis.
机译:目的:研究B甲煎口服液(BOL)对肝纤维化大鼠血浆及正常大鼠肝星状细胞(HSC)中肾素血管紧张素醛固酮系统(RAAS)的影响。我们探索BOL抑制HSC活化的机制,并进一步阐明其抗肝纤维化的机制。方法:SD大鼠随机分为5组:正常对照组,模型组,依那普利组和BOL组,每组分别为2.0 g / ml或1.0 g / ml。除正常组外,每组均给予CCl4和橄榄油溶液诱导肝纤维化。每组用各自的药物治疗5周,然后取血。用放射免疫法检测肝纤维化大鼠血浆中的肾素,血管紧张素Ⅱ和醛固酮水平。通过使用逆转录聚合酶链反应(RT-PCR)来测量肾素,ACE,血管紧张素原,AT1R和ALD的基因表达。通过免疫组织化学测定确定正常HSC中AT1R基因的表达。结果:BOL可有效降低PRA,AngII和ALD的活性,对AngII的抑制作用显着(P <0.01)。同时,与正常对照组相比,含BOL的血清对HSC的PRA有明显的抑制作用(P <0.05)。然而,药物应用组与模型组在RAAS的其他因素方面没有差异。结论:BOL可以抑制正常人HSC中RAAS的表达,抑制肾素mRNA的表达,可能是抗肝纤维化的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号